Universal Health International (2211 HK)

Analysis

Consumer Staples • China

Universal Health International Group Holding Ltd. is an investment holding company primarily engaged in the distribution and retail of drugs, healthcare products, and other pharmaceutical products in the northeastern region of the People's Republic of China. Its product offerings include Chinese patent medicines, chemical preparations, antibiotics, and medical equipment, alongside providing storage services. The company was founded in 1998 and is headquartered in Shenyang, the People's Republic of China.

Refresh

Exchange Announcement • 02 Oct 2026 19:30

Documents On Display

Exchange Announcement • 02 Oct 2026 19:23

Provisional Allotment Letter

Exchange Announcement • 02 Oct 2026 19:21

Proposed Rights Issue On The Basis Of Four (4) Rights Shares For Every One (1) Adjusted Share Held On The Record Date On A Non-Underwritten Basis

Exchange Announcement • 30 Sep 2026 22:17

Annual Results Announcement For The Year Ended 30 June 2026

Exchange Announcement • 23 Sep 2026 06:12

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Documents On Display

Provisional Allotment Letter

Proposed Rights Issue On The Basis Of Four (4) Rights Shares For Every One (1) Adjusted Share Held On The Record Date On A Non-Underwritten Basis

Annual Results Announcement For The Year Ended 30 June 2026

Effective Date Of Capital Reorganisation